 |
Tom F. Lue, MD
Biographical Sketch
| MD, 1972, Kaohsiung Medical College, Taiwan
|
| Urologic Training, 1981, Downstate Medical
Center, State University of New York, Brooklyn, NY |
| Fellowship, 1982, University of California,
San Francisco, CA |
| |
|
| 1982-1983 |
Clinical Instructor, Department of Urology, University
of California, San Francisco, CA |
| 1983-1987 |
Assistant Professor, Department of Urology, University of
California, San Francisco, CA |
| 1987-1992 |
Associate Professor, Department of Urology, University
of California, San Francisco, CA |
| 1992-Present |
Professor, Department of Urology, University of California,
San Francisco, CA |
| 1996-1999 |
Chief of Urology, UCSF Mount Zion Medical Center, University
of California, San Francisco, CA |
| 1997-Present |
Medical Director, Knuppe Molecular Urology Laborabory,
University of California, San Francisco, CA |
1999-Present |
Vice Chairman, Department of Urology, University of California,
San Francisco, CA |
2004-Present |
Emil Tanagho Endowed Chair in Clinical Urology, University
of California, San Francisco, CA |
Tom Lue, MD graduated with highest honors from the Kaohsiung Medical
College in Taiwan in 1972. In 1981, after completing his urologic
training at Downstate Medical Center in Brooklyn, Lue was awarded
the Valentine Fellowship from the New York Academy of Medicine
to study the neurophysiology of the genitourinary tract at the
University of California, San Francisco, Department of Urology.
Lue joined the urology faculty at the University of California,
San Francisco in 1982 as a Clinical Instructor of Urology. He
is presently Professor of Urology. Lue has authored or co-authored
more than 380 publications and 12 books. His major professional
interests are male sexual dysfunction and Peyronie's disease.
He is an internationally recognized expert in penile physiology
research and an authority in the diagnosis and treatment of male
sexual dysfunction.
Lue's basic science research encompasses development of animal
models for research in: penile physiology, hormone deficiency,
cavernous nerve injury, diabetes mellitus and hyperlipidemia.
His research team discovered the anatomical mechanism of venous
compression during penile erection. Lue's clinical research includes
development of diagnostic tests for erectile dysfunction including:
the penile injection and stimulation test, a duplex ultrasound
test for penile arterial flow, and pharmacologic cavernosography
for venous leakage. In 1983 Lue was one of the first urologists
in the country to offer penile injection for patients with erectile
dysfunction. He introduced blood gas determination and color duplex
ultrasound for the differential diagnosis of various types of
priapism.
Lue's team has made important contributions to basic research
and clinical treatment of Peyronie’s disease. He and his
associates published the first article implicating TGF beta in
the formation of Peyronie’s plaque and developed the first
animal model for the study of Peyronie’s disease. He also
introduced colchicines as an effective medical therapy for Peyronie’s
disease.
In 1988 Lue was the recipient of the American Urological Association's
Gold Cystoscope Award. The following year, he was the first recipient
of the American Foundation of Urologic Disease's, "Most Innovative
Research Award." Lue's research team has won many competitions
including first prizes from: the American Urological Association,
the Western Section of the American Urological Assoiation, the
Urodynamics Society, the International Impotence Society, and
the Lapides Essay contest. Lue was Chair of the International
Consultation on Sexual Medicine held in Paris in July 2003, serving
as and the lead author of the meeting's proceedings, which were
published under the title “Sexual Medicine: Sexual Dysfunctions
in Men and Women."
return
to top
|
|
|
|
|
|
